ImetelChat

Karagozoglu12345, check your email for letter updates.

I am not sure you are looking for me to do this but here is my hurried cut, I hope it helps. I won't have much time from here until after Christmas. Your Letter to JS/Geron Dear Dr. Scarlett: Please read this letter and respond freely with the level of detail a most knowledgeable investor and patien...

Well just so you know, I am also in the club with greater than a half million in losses and they are not all paper losses as many options have gone up in smoke as did another chunk today. I likely resonate your pain in all the dimensions you eluded to in your post. Like I said I’m not best suited to...

karagozoglu12345 , I suspect I am not your most effective option here but I could take a cut at editing your letter assuming you don’t have other volunteers. I would have to say that while the questions are good the tone is contentious. I would prefer, that while still being very direct, avoiding po...

Biopearl, I think you are correct on JNJ/Janssen’s future intentions but it is interesting that they did not rescind the other agreement. I think we are all kept in the dark on any activity that is occurring with regards to the license agreement or those patents. I have to wonder also that now JNJ/J...

bucbeard, I enjoyed your analogy and agreed with your thoughts and focus on sending and expecting a significant level of moderation on options, raises and bonuses for 2019. I liked the following post from the latest SA article and find it appealing, maybe what we are looking for and could be a win f...

So continuing on, now that we know the science is in better shape than ever, the focus of the boards seems to be to go after and replace the CEO and BOD, not likely but we can think about it. Will that help? How exactly will that speed up commercialization of Imetelstat? Can the new supposedly young...

bucbeard, I have a lot of thoughts but I cannot find a real anchor point as to hinge an opinion on other than the science continues to shine brightly. Being retired, I do have time to stare at the ceiling and contemplate my navel so take this for what little it is worth. I wonder about a lot of thin...

Latest by FDA Headlines after the December 10th Analyst meeting today:

WHAT LIES AHEAD FOR GERON CORPORATION (NASDAQ:GERN)
Dec 10, 2018 | Business

https://fdaheadlines.com/what-lies-ahea ... asdaqgern/

Here are a couple more articles from FDA Headlines as follow up to the first above: WHY THE BIG NEWS IS ABOUT TO HIT FOR GERON CORPORATION (NASDAQ:GERN) Dec 3, 2018 | Business https://fdaheadlines.com/why-the-big-news-is-about-to-hit-for-geron-corporation-nasdaqgern/ WHY GERON CORPORATION (NASDAQ:GE...

FWIW: https://fdaheadlines.com/geron-corporation-nasdaqgern-jumps-back-into-the-spotlight/#start-read GERON CORPORATION (NASDAQ:GERN) JUMPS BACK INTO THE SPOTLIGHT Nov 28, 2018 | Business Geron Corporation (NASDAQ:GERN) is back in focus again after the company’s CEO just laid down the gauntlet at th...

So what did they learn? Anybody? What conclusions have they reached? I wouldn’t even attempt to summarize all the technical and scientific details / milestones even if it was within my pay grade. There were many for sure but much of it was not made public in a way to formulate conclusions. Enduring ...

I have been contemplating what JS et al at Geron have learned about the TI science covered by the Geron patents and the realities of the challenges in actually getting it to market. One might assume that dozens of studies using Imetelstat have been carried out over the last 4 years along with the CT...

I’m surprised there isn’t more discussion on these items. I know I am not qualified to address it. Hopefully others with the knowledge / experience will help out here. I guess I’m surprised if this is the norm in this day and age of technology and communication. If it all is appropriate, read no fur...

I believe the two license agreements are independent of each other. I sent an email last week to Geron IR regarding the status of the other license agreement but have not received a response. If you check ImetelChat topics for September 17, you will see a post by j6proulx re: The Other Janssen Agree...

Good question and I know your understanding and opinion would be far above anything I could add and sure others here can offer more knowledgeable opinions as well. However, when I looked at the chart, the last transfusion occurred at week 11, so 8 week TI was at week 19 and 24 week TI was at week 33...

You are far from wearing rose colored glasses. Thanks for your post, it is factual and gives some clarity to a confused set of events.

Thanks biopearl, great thoughts again. Therapy for us who know this can't be right but have to deal with the realities.

Well for most of us, a day to let our heads clear is not adequate. What just went down does not compute very well for me and is very painful. Obviously I was totally wrong about JNJ/Janssen on practically every level thinking they could not pass this up. I hope for what it’s worth that all know I sh...

Okay so let’s discuss the skeleton crew at Geron as an indication that Dr. Scarlett is thinking strictly BO. There are other signs (some may say tea leaves) as to what he is considering and what he might be seriously considering. We would do well to remember that JS is not flashy or one to make unju...